Literature DB >> 3052321

Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus.

M A Blaschek1, M Boehme, J Jouquan, A M Simitzis, S Fifas, P Le Goff, P Youinou.   

Abstract

Tests for antivimentin antibodies (AVA) were performed on 50 systemic lupus erythematosus (SLE) and 63 control sera by indirect immunofluorescence and enzyme linked immunosorbent assay (ELISA). The prevalence was significantly raised in SLE (38% and 50% of sera positive for IgM-AVA and IgG-AVA, respectively, by immunofluorescence; 36% and 64% of sera positive for IgM-AVA and IgG-AVA, respectively, by ELISA) in comparison with the control sera. A significant correlation existed between IgM-AVA, on the one hand, and anticardiolipin antibodies (ACA) and anti-single-stranded DNA (ssDNA), on the other. A stepwise principal component analysis demonstrated that IgM-AVA and IgG-AVA accounted for 71% of the total variance in SLE (50 patients x 5 parameters = total variance). Twenty ACA positive serum samples from patients with syphilis were therefore tested for the presence of AVA, but hardly any were found to be positive. IgM-AVA from patients with SLE were inhibited by cardiolipin and absorbed with ssDNA. An association between AVA positivity and arthralgia was also shown in SLE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052321      PMCID: PMC1003586          DOI: 10.1136/ard.47.9.708

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  28 in total

1.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

Review 2.  Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins.

Authors:  E Lazarides
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

3.  Isolation and characterization of intermediate filaments.

Authors:  P Steinert; R Zackroff; M Aynardi-Whitman; R D Goldman
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

4.  Direct demonstration of the presence of two immunologically distinct intermediate-sized filament systems in the same cell by double immunofluorescence microscopy. Vimentin and cytokeratin fibers in cultured epithelial cells.

Authors:  M Osborn; W Franke; K Weber
Journal:  Exp Cell Res       Date:  1980-01       Impact factor: 3.905

5.  IgM autoantibody to intermediate filaments in Mycoplasma pneumoniae infections.

Authors:  L Bretherton; B H Toh; I Jack
Journal:  Clin Immunol Immunopathol       Date:  1981-03

6.  Intermediate filaments as mechanical integrators of cellular space.

Authors:  E Lazarides
Journal:  Nature       Date:  1980-01-17       Impact factor: 49.962

7.  An enzyme-linked immunosorbent assay for antibodies to native and denatured DNA.

Authors:  J L Klotz; R M Minami; R L Teplitz
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.

Authors:  E M Lafer; J Rauch; C Andrzejewski; D Mudd; B Furie; B Furie; R S Schwartz; B D Stollar
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

10.  Antibody to intermediate filaments of the cytoskeleton.

Authors:  O A Osung; M Chandra; E J Holborow
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

View more
  12 in total

1.  Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus.

Authors:  E C De Mendonca Neto; A Kumar; N A Shadick; A M Michon; P Matsudaira; R B Eaton; P Kumar; P H Schur
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 2.  The cytoskeleton and its importance as a mediator of inflammation.

Authors:  K R Rogers; C J Morris; D R Blake
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 3.  Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

4.  Antibodies to intermediate filaments in polymyalgia rheumatica/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response?

Authors:  I Monteagudo; V Corrigall; G S Panayi; G Pountain; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

5.  Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity.

Authors:  M W Boehme; U Raeth; P R Galle; W Stremmel; W A Scherbaum
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

6.  Characterization of the antigen identified by Po66. A monoclonal antibody raised against a lung squamous cell carcinoma.

Authors:  A Martin; P Pellen; C Guitton; P Youinou; B Collet; B Desrues; D Bourel; L Dazord; L Toujas
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.

Authors:  Soung-Chul Cha; Hong Qin; Shibichakravarthy Kannan; Seema Rawal; Leticia S Watkins; Flavio E Baio; Weiguo Wu; Juliana Ong; Jinsong Wei; Benjamin Kwak; Sang Kim; Michael S Popescu; Daniel S Paick; Kunhwa Kim; Amber Luong; Richard E Davis; Harry W Schroeder; Larry W Kwak; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

Review 8.  Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.

Authors:  Savino Sciascia; Mary-Carmen Amigo; Dario Roccatello; Munther Khamashta
Journal:  Nat Rev Rheumatol       Date:  2017-08-03       Impact factor: 20.543

Review 9.  Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies".

Authors:  Valeria Manganelli; Antonella Capozzi; Serena Recalchi; Michele Signore; Vincenzo Mattei; Tina Garofalo; Roberta Misasi; Mauro Degli Esposti; Maurizio Sorice
Journal:  J Immunol Res       Date:  2015-09-29       Impact factor: 4.818

10.  Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome.

Authors:  Vera M Ripoll; Anastasia Lambrianides; Silvia S Pierangeli; Katie Poulton; Yiannis Ioannou; Wendy E Heywood; Kevin Mills; David S Latchman; David A Isenberg; Anisur Rahman; Ian P Giles
Journal:  Blood       Date:  2014-10-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.